Dr. Arpit Jain

Professional Journey

Achievements

• Coordinated and engaged in various symposiums, webinars, and meetings.
• Authored chapters on “Chemotherapy for Prostate Cancer” and “Recent Advances in Cancer Immunotherapy Management.”
• Presented both oral and poster sessions in several national oncology conferences.
• Participated as a speaker at various National Oncological Conferences.

Awards

• Honoured for exceptional research in lung cancer molecular diagnostics by NBE, 2022
• Achieved the top academic performance during postgraduate study.
• Attained distinctions in several subjects throughout the MBBS curriculum.

Research Contributions

• Conducted thesis work during MD Radiation Oncology, focusing on a prospective study comparing treatment strategies for locally advanced squamous cell carcinoma of the head and neck.
• Conducted research comparing the efficacy of liquid biopsy and tissue biopsy for detecting EGFR mutations in non-small cell lung carcinoma (NSCLC)

Publication

• Soni S, Jain A, Goyal V, Narayan S, Redhu P, Talwar V. “Modified FOLFIRINOX as the first-line chemotherapy in unresectable and metastatic pancreatic adenocarcinoma – a single-center experience in India.” Annals of Pancreatic Cancer. 2023.
• Jain A, Soni S, Redhu P, et al. “Autoimmune Haemolytic Anaemia Associated with Testicular Non-seminomatous Germ Cell Tumour (NSGCT): A Unique Paraneoplastic Presentation.”
• Soni S, Jain A, et al. “Hair Depigmentation in a Patient Treated with Pazopanib: A Case Report and Comprehensive Analysis.” Indian Journal of Skin Allergy. February 2024.
• Narayan S, Talwar V, Redhu P, Goel V, Jain A, Soni S, et al. “Serpentine Supra-venous Hyperpigmentation ‘Badge of Courage’ in Fight Against Cancer: A Brief Review.” Gulf Journal of Oncology. 2022 Sep;1(40):83-7.
• Jain A, Koyyala VP, Narayan S, et al. “Hyper-Progressive Disease (HPD) during Immune Checkpoint Inhibitor (ICI) Therapy.” Indian Journal of Medical and Paediatric Oncology. 2022 Apr 18;43(02):185-8.
• Jain A, Joga S, Patel AB. “The Cost Containment Strategy by Optimizing the Bevacizumab Dose for Glioblastoma: Worthy or Not?” Cancer Research, Statistics, and Treatment. 2021 Jul 1;4(3):579-80.
• Goyal V, Jain A, et al. “Unveiling the Uncommon: Disseminated Intravascular Coagulation as an Unusual Presentation of Metastatic Carcinoma Prostate.” IP Archives of Cytology and Histopathology Research. 2023;8(2):119-122.
• Talwar V, Jain A. “The Genetic Basis of Breast Cancer: A Comprehensive Overview.” Current Medical Research and Practice. 2023.
• Bansal N, Goyal P, Basu D, et al. “Impact of Improving Infection Control and Antibiotic Stewardship Practices on Nosocomial Infections and Antimicrobial Resistance in an Oncology Centre from India.” Indian Journal of Medical Microbiology. 2023 Sep 1; 45:100383.
• Batra U, Nathany S, Sharma M, Jain P, Dhanda S, Singh H, Jain A, Mehta A. “EGFR Detection by Liquid Biopsy: Ripe for Clinical Usage.” Future Oncology. 2021 Sep;18(1):85-92.
• Narayan S, Talwar V, Goel V, Chaudhary K, Sharma A, Redhu P, Soni S, Jain A. “Co-relation of SARS-CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy.” World Journal of Clinical Oncology. 2022 May 5;13(5):339.
• Jain A, Jaju A, Iyer M, Arya R, Jain P. “Metastases of malignant melanoma to stomach – An unusual presentation.” Indian Journal of Pathology and Oncology. 2020;7(3):480-482.
• “Real World Experience with Osteosarcoma from a Tertiary Cancer Centre in India.” Journal of Cancer Science and Clinical Therapeutics. January 2023.
• Sharma M, Nathany S, Soni S, Jain A, Mehta A, Jain P, Batra U. “Spectrum of BRAF mutations in Indian patients with NSCLC: A molecular kaleidoscope.”
• Mathigatta Shivarudraiah, Shivashankara & Pathak, Jain A, Abhishek. (2022). “How ctDNA Changing the Landscape of Management of Colorectal Cancers.” Indian Cancer Awareness Journal.
• “Outcome and Complications of Microvascular Free Flap Head and Neck Reconstruction Analysis of 200 Cases.” International Journal of Medical and Oral Research. January-June 2018.
• Verma M, Jain A, Shivhare V, Katariya S, George A, Iyer M, Malviya A, Singh AP. “A prospective study to compare the response and toxicity in patients treated with concomitant boost radiotherapy versus conventional radiotherapy in (LA-HNSCC).” Journal of Evolution of Medical and Dental Sciences. 2019 Mar 25;8(12):868-72.
• Katariya S, Verma M, Jain A, Shivhare V, George A, Iyer M, Malviya A, Singh AP. “An institutional study to evaluate the efficacy and toxicity of reirradiation using conventional radiotherapy for recurrent malignant disease.” Journal of Evolution of Medical and Dental Sciences. 2019 Jan 21;8(3):174-7.

Abstracts

• “Matched-Pair Analysis of mFOLFIRINOX vs. Gemcitabine+Nab-paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma: Survival and Toxicity Outcomes.” ESMO GI Congress 2024.
• “Evaluating Tumor Regression Grade in Locally Advanced Rectal Cancer: Identifying Predictive Factors and Clinical Implications Following Neoadjuvant Chemoradiotherapy.” ESMO GI Congress 2024.
• “Real World Experience with Cyclin Dependent Kinase Inhibitors in Metastatic Breast Cancer Patients from India.” ASCO 2024.
• “Survival and Safety Analysis of Eribulin in Indian Metastatic Breast Cancer Patients: A Real-World Clinical Experience.” ASCO 2024.
• “Molecular Subtypes of Colorectal Cancer and Their Correlation with Clinical and Pathological Profile in a Tertiary Care Centre in India.” Annals of Oncology. 2022 Jun 1;33: S253-4.
• “Are All ALK Gene Rearrangements Created Equal?” Journal of Thoracic Oncology. Vol. 16 No. 3S; March 2021.